The Practical Application of Three Validated In Vitro Embryotoxicity Tests

Brown N.A. , Spielmann H. , Bechter R. , Flint O.P. , Freeman S.J. , Jelinek R.J. , Koch E. , Nau H. , Newall D.R. , Palmer A.K. , Renault J.Y. , Repetto M. , Vogel R. , & Wigler R. (1995). Screening chemicals for reproductive toxicity: the current alternatives. The report and recommendations of an ECVAM/ETS workshop (ECVAM Workshop 12). ATLA 23, 868–882.

Genschow E. , Spielmann H. , Scholz G. , Seiler A. , Brown N.A. , Piersma A. , Brady M. , Clemann N. , Huuskonen H. , Paillard F. , Bremer S. , & Becker K. (2002). The ECVAM international validation study on in vitro embryotoxicity tests. Results of the definitive phase and evaluation of prediction models. ATLA 30, 151–176.

ESAC (2002). The use of scientifically validated in vitro tests for embryotoxicity. ATLA 30, 265–273.

Genschow E. , Spielmann H. , Scholz G. , Pohl I. , Seiler A. , Clemann N. , Bremer S. , & Becker K. (2004). Validation of the embryonic stem cell test (EST) in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 209–244.

Piersma A.H. , Genschow E. , Verhoef A. , Spanjersberg M.Q.I. , Brown N.A. , Brady M. , Burns A. , Clemann N. , Seiler A. , & Spielmann H. (2004). Validation of the rat postimplantation whole embryo culture (WEC) test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 275–307.

Spielmann H. , Genschow E. , Brown N.A. , Piersma A.H. , Verhoef A. , Spanjersberg M.Q.I. , Huuskonen H. , Paillard F. , & Seiler A. (2004). Validation of the postimplantation rat limb bud micromass (MM) test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 245–274.

Genschow E. , Scholz G. , Brown N. , Piersma A. , Brady M. , Clemann N. , Huuskonen H. , Paillard F. , Bremer S. , Becker K. , & Spielmann H. (2000). Development of prediction models for three in vitro embryotoxicity tests. In Vitro and Molecular Toxicology 13, 51–65

Brown N.A. (2002). Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. ATLA 30, 177–198.

OECD (1996). Final Report of the OECD Workshop on Harmonisation of Validation and Acceptance Criteria for Alternative Toxicological Test Methods. 60 pp. Paris, France: OECD.

Spielmann H. , Pohl I. , Döring B. , Liebsch M. , & Moldenhauer F. (1997). The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicology 10, 119–127.

Scholz G. , Genschow E. , Pohl I. , Bremer S. , Paparella M. , Raabe H. , Moldenhauer F. , Southee J.A. , & Spielmann H. (1999). Prevalidation of the embryonic stem cell test (EST), a new in vitro embryotoxicity test. Toxicology in Vitro 13, 675–681.

Kistler A. (1987). Limb bud cell cultures for estimating the teratogenic potential of compounds: Validation of the test system with retinoids. Archives of Toxicology 60, 403–414.

Hareng L. , Pellizzer C. , Bremer S. , Schwarz M. , & Hartung T. (2005). The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. Reproductive Toxicology 20, 441–452.

Zur Nieden N.I. , Kempka G. , & Ahr H.J. (2004). Molecular multiple endpoint embryonic stem cell test — a possible approach to test for the teratogenic potential of compounds. Toxicology and Applied Pharmacology 194, 257–269.

Seiler A. , Visan A. , Buesen R. , Slawik B. , Genschow E. , & Spielmann H. (2004). Improvement of an in vitro stem cell assay (EST) for developmental toxicity by establishing molecular endpoints of tissue-specific development. Reproductive Toxicology 18, 231–240.

Seiler A. , Buesen R. , Hayess K. , Schlechter K. , Visan A. , Genschow E. , Slawik B. , & Spielmann H. (2006). Current status of the embryonic stem cell test: the use of recent advances in the field of stem cell technology and gene expression analysis. ALTEX, in press.

Bremer S. , Worth A.P. , Paparella M. , Bigot K. , Kolossov E. , Fleischmann B.K. , Hescheler J. , & Balls M. (2001). Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. Toxicology in Vitro 15, 215–223.

Paparella M. , Kolossov E. , Fleischmann B.K. , Hescheler J. , & Bremer S. (2002). The use of quantitative image analysis in the assessment of in vitro embryotoxicity endpoints based on a novel embryonic stem cell clone with endoderm-related GFP expression. Toxicology in Vitro 16, 589–597.

Pellizzer C. , Bello E. , Adler S. , Hartung T. , & Bremer S. (2004). Detection of tissue-specific effects by methotrexate on differentiating mouse embryonic stem cells. Birth Defects Research Part B: Developmental and Reproductive Toxicology 71, 331–341.

Pellizzer C. , Adler S. , Corvi R. , Hartung T. , & Bremer S. (2004). Monitoring of teratogenic effects in vitro by analysing a selected gene expression pattern. Toxicology in Vitro 18, 325–335.

Verwei M. , van Burgsteden J.A. , Krul C.A.M. , van de Sandt J.J.M. , & Freidig A.P. (2006). Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. Toxicology Letters 165, 79–87.

Gülden M. , & Seibert H. (2003). In vitro–in vivo extrapolations: estimation of human serum concentrations of chemicals equivalent to cytotoxic concentrations in vitro. Toxicology 189, 211–222.